These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27076228)

  • 1. Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature.
    Petrovski S; Parrott RE; Roberts JL; Huang H; Yang J; Gorentla B; Mousallem T; Wang E; Armstrong M; McHale D; MacIver NJ; Goldstein DB; Zhong XP; Buckley RH
    J Clin Immunol; 2016 Jul; 36(5):462-71. PubMed ID: 27076228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cɛ) impairing TORC2-dependent AKT activation.
    Alcantara D; Elmslie F; Tetreault M; Bareke E; Hartley T; ; Majewski J; Boycott K; Innes AM; Dyment DA; O'Driscoll M
    Hum Mol Genet; 2017 Oct; 26(19):3713-3721. PubMed ID: 28934384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in PIK3R1 cause SHORT syndrome.
    Dyment DA; Smith AC; Alcantara D; Schwartzentruber JA; Basel-Vanagaite L; Curry CJ; Temple IK; Reardon W; Mansour S; Haq MR; Gilbert R; Lehmann OJ; Vanstone MR; Beaulieu CL; ; Majewski J; Bulman DE; O'Driscoll M; Boycott KM; Innes AM
    Am J Hum Genet; 2013 Jul; 93(1):158-66. PubMed ID: 23810382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.
    Lucas CL; Zhang Y; Venida A; Wang Y; Hughes J; McElwee J; Butrick M; Matthews H; Price S; Biancalana M; Wang X; Richards M; Pozos T; Barlan I; Ozen A; Rao VK; Su HC; Lenardo MJ
    J Exp Med; 2014 Dec; 211(13):2537-47. PubMed ID: 25488983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.
    Thauvin-Robinet C; Auclair M; Duplomb L; Caron-Debarle M; Avila M; St-Onge J; Le Merrer M; Le Luyer B; Héron D; Mathieu-Dramard M; Bitoun P; Petit JM; Odent S; Amiel J; Picot D; Carmignac V; Thevenon J; Callier P; Laville M; Reznik Y; Fagour C; Nunes ML; Capeau J; Lascols O; Huet F; Faivre L; Vigouroux C; Rivière JB
    Am J Hum Genet; 2013 Jul; 93(1):141-9. PubMed ID: 23810378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two.
    Bravo García-Morato M; García-Miñaúr S; Molina Garicano J; Santos Simarro F; Del Pino Molina L; López-Granados E; Ferreira Cerdán A; Rodríguez Pena R
    Clin Immunol; 2017 Jun; 179():77-80. PubMed ID: 28302518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3R1 mutations in SHORT syndrome.
    Schroeder C; Riess A; Bonin M; Bauer P; Riess O; Döbler-Neumann M; Wieser S; Moog U; Tzschach A
    Clin Genet; 2014 Sep; 86(3):292-4. PubMed ID: 23980586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome.
    Bárcena C; Quesada V; De Sandre-Giovannoli A; Puente DA; Fernández-Toral J; Sigaudy S; Baban A; Lévy N; Velasco G; López-Otín C
    BMC Med Genet; 2014 May; 15():51. PubMed ID: 24886349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APDS2 and SHORT Syndrome in a Teenager with PIK3R1 Pathogenic Variant.
    Ramirez L; Tamayo W; Ale H
    J Clin Immunol; 2020 Oct; 40(7):1020-1025. PubMed ID: 32778990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PIK3R1 mutation of SHORT syndrome in a Chinese female with diffuse thyroid disease: a case report and review of literature.
    Sun L; Zhang Q; Li Q; Tang Y; Wang Y; Li X; Li N; Wang J; Wang X
    BMC Med Genet; 2020 Oct; 21(1):215. PubMed ID: 33129256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT Syndrome.
    Prontera P; Micale L; Verrotti A; Napolioni V; Stangoni G; Merla G
    Hum Mutat; 2015 Nov; 36(11):1043-7. PubMed ID: 26252249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3R1 Mutation Associated with Hyper IgM (APDS2 Syndrome): A Case Report and Review of the Literature.
    Yazdani R; Hamidi Z; Babaha F; Azizi G; Fekrvand S; Abolhassani H; Aghamohammadi A
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):941-958. PubMed ID: 30799802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant PIK3R1 mutations cause SHORT syndrome.
    Chung BK; Gibson WT
    Clin Genet; 2014 Mar; 85(3):228-9. PubMed ID: 24033310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects.
    Bildik HN; Esenboga S; Halaclı SO; Karaatmaca B; Aytekin ES; Nabiyeva N; Akarsu A; Ocak M; Erman B; Tan C; Arikoglu T; Yaz I; Cicek B; Tezcan I; Cagdas D
    Pediatr Allergy Immunol; 2024 Sep; 35(9):e14245. PubMed ID: 39312287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes.
    Solheim MH; Winnay JN; Batista TM; Molven A; Njølstad PR; Kahn CR
    Diabetes; 2018 Jul; 67(7):1297-1309. PubMed ID: 29724723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHORT syndrome in two Chinese girls: A case report and review of the literature.
    Zhang Y; Ji B; Li J; Li Y; Zhang M; Ban B
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1385. PubMed ID: 32602265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
    Negishi Y; Miya F; Hattori A; Johmura Y; Nakagawa M; Ando N; Hori I; Togawa T; Aoyama K; Ohashi K; Fukumura S; Mizuno S; Umemura A; Kishimoto Y; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Nakanishi M; Saitoh S
    BMC Med Genet; 2017 Jan; 18(1):4. PubMed ID: 28086757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological assessment of APDS2 with features of the SHORT syndrome related to a novel mutation in
    Szczawińska-Popłonyk A; Bernat-Sitarz K; Schwartzmann E; Piechota M; Badura-Stronka M
    Allergol Immunopathol (Madr); 2022; 50(4):1-9. PubMed ID: 35789397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PIK3R1 mutation of SHORT syndrome: A case report with a 6-month follow up.
    Yin X; Liu J; Feng R; Xu M; Liu J
    J Diabetes Investig; 2021 Oct; 12(10):1919-1922. PubMed ID: 33742773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of B-cell intracellular signaling by monitoring the PI3K-Akt axis in patients with common variable immunodeficiency and activated phosphoinositide 3-kinase delta syndrome.
    Del Pino-Molina L; Torres Canizales JM; Rodríguez-Pena R; López-Granados E
    Cytometry B Clin Cytom; 2021 Jul; 100(4):460-466. PubMed ID: 32961022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.